CSPI sues Bayer over prostate claims
This article was originally published in The Tan Sheet
Executive Summary
The Center for Science in the Public Interest makes good on its threat to sue Bayer over claims linking selenium in its One A Day Men's multivitamins to reduced risk of prostate cancer. The 1complaint, filed Sept. 30 in California state court in San Francisco, acknowledges Bayer removed prostate claims from its Web site but says it did not meet other CSPI demands, including recalling products with the claims and agreeing not to make the claims in the future (2"The Tan Sheet" Aug. 17, 2009). CSPI asks the court to find Bayer in violation of the Consumer Legal Remedies Act and the Unfair Competition Law, and seeks relief for itself and its members. In a Sept. 2 letter attached to the complaint, Bayer threatens to sue CSPI for "false, misleading and defamatory" communications about the One A Day products. A Bayer spokeswoman declined to comment on whether the firm will sue